Vir Biotechnology, Inc. (VIR)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 8.74 |
| Open | 8.91 |
| Bid | 9.18 x 300 |
| Ask | 9.23 x 100 |
| Day's range | 8.74 - 9.20 |
| 52-week range | 7.61 - 27.48 |
| Volume | |
| Avg. volume | 1,034,881 |
| Market cap | 1.247B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
With 53% ownership, Vir Biotechnology, Inc. (NASDAQ:VIR) boasts of strong institutional backing
Key Insights Institutions' substantial holdings in Vir Biotechnology implies that they have significant influence over...
- Zacks
What Makes Vir Biotechnology (VIR) a New Buy Stock
Vir Biotechnology (VIR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
- GuruFocus.com
Vir Biotechnology Inc CEO Backer De Sells 72,995 Shares
Vir Biotechnology Inc (NASDAQ:VIR), a company focused on the research and development of treatments for serious infectious diseases, has reported an insider sell according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.